mdh.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
A structure-activity study of nociceptin-(1-13)-peptide amide. Synthesis of analogues substituted in positions 0, 1, 3, 4 and 10.
Institute of Organic Synthesis, Riga, Latvia .
Medical University, Sofia, Bulgaria.
Institute of Physiology, Sofia, Bulgaria .
Institute of Bioorganic Chemistry, Moscow, Russian Federation .
Show others and affiliations
2003 (English)In: European journal of medicinal chemistry, ISSN 0223-5234, Vol. 38, no 7-8, 687-694 p.Article in journal (Refereed) Published
Abstract [en]

A series of analogues of nociceptin, Noc(1-13)NH(2) (an agonist at the ORL1 receptor) was synthesized with following modifications: (1) N-terminal extension with Arg(0); (2) replacement of Gly(3) by basic or polar amino acids-Arg, Asn, Lys(For) or deletion; (3) exchange of Phe(1) or Phe(4) by Phe(NO(2)); (4) substitution of Ser(10) with D-Ser, Pro, D-Pro. The analogs were synthesized by solid-phase methodology using Fmoc-amino acid pentafluorophenyl esters. The affinity for the ORL1 and for the kappa, micro and delta-opioid receptors was investigated by radioligand binding assay and bioactivity by a mouse vas deferens (MVD) assay. The addition of the amino acid residue Arg to the N-terminal enhances the opioid receptor affinity of Noc(1-13)NH(2) while retaining ORL1 receptor affinity at a moderate level. The replacement of Gly in position 3 by the basic or polar amino acids-Arg, Asn, Lys(For) or its deletion led to inactive analogues. The replacement of Ser in position 10 by its D-isomer, Pro and D-Pro resulted in a series of analogues with the following order of activity: Ser(10)>D-Ser(10)>Pro(10)>D-Pro(10). In [D-Ser(10)]Noc(1-13)NH(2), introduction of an additional Phe(NO(2))(4) led to a >60-fold increase of ORL1 affinity, completely attenuating the loss of affinity brought about by Ser(10). In other analogues, introduction of Phe(NO(2))(4) did not change the magnitude of ORL1 binding significantly. Generally, while modifications in position 3 frequently led to a loss of most or all bioactivity, modifications in position 0 (Arg(0)) or 4 (Phe(NO(2))(4)) and 10 (D-Ser(10), Pro(10)) are tolerated.

Place, publisher, year, edition, pages
2003. Vol. 38, no 7-8, 687-694 p.
Keyword [en]
Amino Acid Substitution, Animals, Binding Sites, Comparative Study, Ligands, Male, Mice, Opioid Peptides/chemical synthesis/*chemistry/pharmacology, Peptide Fragments/chemical synthesis/*chemistry/pharmacology, Radioligand Assay, Receptors; Opioid/*agonists/chemistry/metabolism, Research Support; Non-U.S. Gov't, Structure-Activity Relationship, Vas Deferens/drug effects/metabolism
National Category
Medicinal Chemistry
Identifiers
URN: urn:nbn:se:mdh:diva-3315DOI: 10.1016/S0223-5234(03)00087-4ISI: 000185622500004PubMedID: 12932899Scopus ID: 2-s2.0-0043158870OAI: oai:DiVA.org:mdh-3315DiVA: diva2:115979
Available from: 2006-03-09 Created: 2006-03-09 Last updated: 2015-07-07Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Johansson, LarsErik
By organisation
Department of Biology and Chemical Engineering
Medicinal Chemistry

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 77 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf